810209P

C6-NBD Ceramide

Avanti Research^™ - A Croda Brand

• Synonim(y): N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine
• Wzór empiryczny (zapis Hilla): C₃₀H₄₉N₅O₆
• Numer CAS: 94885-02-6
• Masa cząsteczkowa: 575.74
• Kod UNSPSC: 12352211
• NACRES: NA.25

Właściwości

• Próba: >99% (TLC)
• Postać: powder
• opakowanie: pkg of 1 × 1 mg (810209P-1mg)
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand
• Warunki transportu: dry ice
• temp. przechowywania: −20°C
• InChI: 1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
• Klucz InChI: HZIRBXILQRLFIK-VPZZKNKNSA-N

Opis

Opis ogólny

C6-NBD ceramide is a fluorescent labelled compound, known to be useful for the detection of enzymatic action. C6-NBD ceramide is preferred over radioactive compounds.

Zastosowanie

C6-NBD Ceramide is suitable as a substrate for sphingomyelin synthase activity assay.

Działania biochem./fizjol.

Ceramide is one of the products of sphingolipid metabolism. The members of ceramide synthases family are responsible for its synthesis. Each ceramide synthesized differs in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.

Opakowanie

5 mL Amber Glass Screw Cap Vial (810209P-1mg)

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids